An impression on current developments in the technology, chemistry, and biological activities of ginger (Zingiber officinale Roscoe) - PubMed (original) (raw)

Review

An impression on current developments in the technology, chemistry, and biological activities of ginger (Zingiber officinale Roscoe)

I Rahath Kubra et al. Crit Rev Food Sci Nutr. 2012.

Abstract

Ginger rhizome (Zingiber officinale Roscoe) is widely cultivated as a spice for its aromatic and pungent components. The essential oil and oleoresins from ginger are valuable products responsible for the characteristic flavor and pungency. Both are used in several food products such as soft beverages and also in many types of pharmaceutical formulations. More than 100 compounds have been reported from ginger, some of which are isolated and characterized, others are tentatively identified by GC-MS and / or LC-MS. [6]-Gingerol, the major gingerol in ginger rhizomes, has been found to possess many interesting pharmacological and physiological activities, such as anti-inflammatory, analgesic, and cardiotonic effects. Ginger is considered as "generally recognized as safe" (GRAS) by Food and Drug Administration (FDA), USA. Due to all these properties, ginger has gained considerable attention in developed countries in recent years, especially for its use in the treatment of inflammatory conditions. The present review is a persuasive presentation of the current information on processing, chemistry, biological activities, and medicinal uses of ginger. Further studies are required for the validation of the beneficial uses. Formulation for novel products and new usages may emerge in the years to come, based on the revealed results of various studies.

PubMed Disclaimer

Cited by

Estimation of the binding modes with important human cytochrome P450 enzymes, drug interaction potential, pharmacokinetics, and hepatotoxicity of ginger components using molecular docking, computational, and pharmacokinetic modeling studies.
Qiu JX, Zhou ZW, He ZX, Zhang X, Zhou SF, Zhu S. Qiu JX, et al. Drug Des Devel Ther. 2015 Feb 16;9:841-66. doi: 10.2147/DDDT.S74669. eCollection 2015. Drug Des Devel Ther. 2015. PMID: 25733806 Free PMC article.
[10]-Gingerdiols as the major metabolites of [10]-gingerol in zebrafish embryos and in humans and their hematopoietic effects in zebrafish embryos.
Chen H, Soroka DN, Haider J, Ferri-Lagneau KF, Leung T, Sang S. Chen H, et al. J Agric Food Chem. 2013 Jun 5;61(22):5353-60. doi: 10.1021/jf401501s. Epub 2013 May 23. J Agric Food Chem. 2013. PMID: 23701129 Free PMC article.
The Role of 6-Gingerol on Inhibiting Amyloid β Protein-Induced Apoptosis in PC12 Cells.
Zeng GF, Zong SH, Zhang ZY, Fu SW, Li KK, Fang Y, Lu L, Xiao DQ. Zeng GF, et al. Rejuvenation Res. 2015 Oct;18(5):413-21. doi: 10.1089/rej.2014.1657. Epub 2015 Aug 20. Rejuvenation Res. 2015. PMID: 25811848 Free PMC article.
Protective Effects of 6-Shogaol, an Active Compound of Ginger, in a Murine Model of Cisplatin-Induced Acute Kidney Injury.
Gwon MG, Gu H, Leem J, Park KK. Gwon MG, et al. Molecules. 2021 Sep 30;26(19):5931. doi: 10.3390/molecules26195931. Molecules. 2021. PMID: 34641472 Free PMC article.
Synergistic Inhibition of Pro-Inflammatory Pathways by Ginger and Turmeric Extracts in RAW 264.7 Cells.
Zhou X, Münch G, Wohlmuth H, Afzal S, Kao MT, Al-Khazaleh A, Low M, Leach D, Li CG. Zhou X, et al. Front Pharmacol. 2022 May 19;13:818166. doi: 10.3389/fphar.2022.818166. eCollection 2022. Front Pharmacol. 2022. PMID: 35662723 Free PMC article.

An impression on current developments in the technology, chemistry, and biological activities of ginger (Zingiber officinale Roscoe) - PubMed (original) (raw)